| PERIOD ENDING | 31-Jan-05 | 31-Jan-04 | 31-Jan-03 | | Total Revenue | 959,442 | 765,892 | 735,889 | | Cost of Revenue | 380,710 | 327,560 | 338,121 | | | Gross Profit | 578,732 | 438,332 | 397,768 | | | Operating Expenses | | Research Development | 236,657 | 216,457 | 232,593 | | Selling General and Administrative | 290,445 | 254,376 | 281,202 | | Non Recurring | 4,697 | (2,123) | 66,714 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 46,933 | (30,378) | (182,741) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 40,253 | 45,938 | 56,557 | | Earnings Before Interest And Taxes | 87,186 | 15,560 | (126,184) | | Interest Expense | 4,030 | 6,980 |
-
| | Income Before Tax | 83,156 | 8,580 | (126,184) | | Income Tax Expense | 13,214 | 8,206 | 3,294 | | Minority Interest | (12,612) | (5,760) |
-
| | | | Net Income From Continuing Ops | 57,330 | (5,386) | (129,478) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 57,330 | (5,386) | (129,478) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $57,330 | ($5,386) | ($129,478) |
|
0.22% Nasdaq 
Income Statement
